Clinical Trial 50927

Berlin, NJ 08009


A double-blind, placebo-controlled, Phase IIb, multi-center, 10-week prospective study to evaluate the efficacy and safety of NOE-105 in adult male patients with childhood onset fluency disorder.

  • Be 18-50 years old
  • Be male
  • Have childhood onset fluency disorder (stuttering)
  • Discontinue all medications used to treat stuttering for at least 14 dyas prior to screening
  • Have a history of stuttering for 2 years with onset conistent to developmental in nature before age 8 years

Qualified Participants May Receive:

  • Up to $2,810 for time and travel
  • No insurance needed and transportation available

Available At:

CenExel HRI
175 Cross Keys Rd.
Berlin, NJ 08009
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.